SCHEMBL5010225

SCHEMBL5010225

F[C]1COc2ccccc2O1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.46
ITGB2 P05107 1/20 0.46
ICAM1 P05362 1/20 0.46
ITGAL P20701 1/20 0.46
LMNA P02545 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
CRHBP P24387 2/20 0.41
CRHR2 Q13324 2/20 0.41
MAOA P21397 2/20 0.41
MAOB P27338 2/20 0.41
HTT P42858 1/20 0.41
AHR P35869 1/20 0.34
OXTR P30559 1/20 0.34
GAA P10253 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6269163 0.73 LMNA (0.66) ABCG2ITGB2ICAM1ITGALLMNA
SCHEMBL13950594 0.71 ABCG2 (0.46) ABCG2ITGB2ICAM1ITGALLMNA
SCHEMBL438269 0.71 ABCG2 (0.46) ABCG2ITGB2ICAM1ITGALLMNA
SCHEMBL279547 0.71 ABCG2 (0.46) ABCG2ITGB2ICAM1ITGALLMNA
SCHEMBL29966720 0.71 ABCG2 (0.46) ABCG2ITGB2ICAM1ITGALLMNA
SCHEMBL1038843 0.71 ABCG2 (0.46) ABCG2ITGB2ICAM1ITGALLMNA
SCHEMBL442811 0.71 ABCG2 (0.46) ABCG2ITGB2ICAM1ITGALLMNA
SCHEMBL2422652 0.71 ABCG2 (0.46) ABCG2ITGB2ICAM1ITGALLMNA
SCHEMBL8674765 0.69 ITGB2 (0.82) ABCG2ITGB2ICAM1ITGALLMNA
SCHEMBL15313020 0.68 MAOA (0.48) ABCG2ITGB2ICAM1ITGALLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492431-B2 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity JANSSEN PHARMACEUTICA, N.V. (BE) 2013-07-23 US claimed
EP-1968573-A2 USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MANIA AND BIPOLAR DISORDER Janssen Pharmaceutica, N.V. (BE) 2008-09-17 EP claimed
WO-2007075695-A2 USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MANIA AND BIPOLAR DISORDER JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-05 WO claimed